Evaluating the Teratogenicity of Ritodrine and Nifedipine using a Frog Embryo Teratogenesis assay (FETAX)

References

• Abel MH, Hollingsworth M. (1986). Comparison of nifedipine and diltiazem with salbutamol for prevention of preterm delivery in the ovariectomized, oestrogen-treated late pregnant rat. J Reprod Fertil 77:559–568
   PubMedGoogle Scholar
• American Society for Testing and Materials (ASTM). (1991). Standard Guide for Conducting the Frog Embryo Teratogenesis Assay—Xenopus (FETAX). ASTM E1439—91. In: Annual Book of ASTM Standards, Philadelphia
   Google Scholar
• American Society for Testing and Materials (ASTM). (1998). Standard Guide for Conducting the Frog Embryo Teratogenesis Assay—Xenopus (FETAX). ASTM E1439—98. In: Annual Book of ASTM Standards, Philadelphia
   Google Scholar
• American Society for Testing Materials (ASTM). (2004). ASTM E1439-98. Standard Guide for Conducting the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). In: ASTM standards on biological effects and environmental fate. Available at: http://www.astm.org/DATABASE.CART/HISTORICAL/E1439-98.htm. Accessed on July 22, 2013
   Google Scholar
• Anotayanonth S, Subhedar NV, Garner P, et al. (2004). Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 4:CD004352
   PubMedGoogle Scholar
• Aydın A. (2005). Preterm Eylemin Durdurulmasında Ritodrin Ve Nifedipinin Tedavi Etkinliklerinin, Maternal Ve Fetal Etkilerinin Karşılaştırılması., T.C.Sağlık Bakanlığı Zeynep Kamil Kadın Ve Cocuk Hastalıkları Eğitim ve Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Kliniği, Istanbul, Turkey. Available at: www.istanbulsaglik.gov.tr/w/tez/pdf/kadin_hast/dr_arzu_aydin.pdf. Accessed on July 22, 2013
   Google Scholar
• Bantle JA, Fort DJ, James BL. (1989). Identification of developmental toxicants using the Frog Embryo Teratogenesis Assay—Xenopus (FETAX). Hydrobiol 188/189:577–585
   Web of Science ®Google Scholar
• Bantle JA, Burton DT, Dawson DA, et al. (1994). Initial interlaboratory validation study of FETAX: phase I testing. J Appl Toxicol 14:213–223
   PubMed Web of Science ®Google Scholar
• Barden TP, Peter JB, Merkatz IR. (1980). Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. I. pharmacology, clinical history, administration, side effects, and safety. Obstet Gynecol 56:1–6
   PubMed Web of Science ®Google Scholar
• Bernal AL. (2007). The regulation of uterine relaxation. Review. Semin Cell Dev Biol 18:340–347
   PubMed Web of Science ®Google Scholar
• Boga A, Binokay S, Emre M, Sertdemir Y. (2012). The embryonic development of Xenopus laevis under a low frequency electric field. In Vitro Cell Dev Biol Anim 48:385–391
   PubMed Web of Science ®Google Scholar
• Boga A, Binokay S, Kendirci A. (1997). Experimental embryology in Xenopus laevis. Turk J Biol 21:141–148
   Google Scholar
• Boga A, Binokay S, Kızılkanat E, et al. (2000). Morphological changes in Xenopus laevis embryos with lithium and evaluation of the FETAX test. Turk J Biol 24:177–188
   Google Scholar
• Boga A, Binokay S, Sertdemir, Y. (2009). The toxicity and teratogenicity of gibberellic acid (GA3) based on the frog embryo teratogenesis assay-Xenopus (FETAX). Turk J Biol 33:181–188
   Web of Science ®Google Scholar
• Boğa A, Erdogan S, Sertdemir Y. (2008). Effect of spesific dosages of magnesium and zinc on the teratogenicity of cadmium, nickel, and cobalt in Xenopus embryos, as assessed by the FETAX test. Dose-Response 6:16–29
   Google Scholar
• Brazy JE, Pupkin MJ. (1979). Effects of maternal isoxsuprine administration on preterm infants. J Pediatr 94:444–448
   PubMed Web of Science ®Google Scholar
• Burgess AM, Vere DW. (1989). Teratogenic effects of some calcium channel blocking agents in Xenopus embryos. Pharmacol Toxicol 64:78–82
   PubMedGoogle Scholar
• Creasy RK, Golbus MS, Laros RK Jr, et al. (1980). Oral ritodrine maintenance in treatment of prematüre labor. Am J Obstet Gynecol 137:212–209
   PubMed Web of Science ®Google Scholar
• Dengiz GA, Akpınar E. (2007). Anti-inflammatory effects of L-Type Calcium channel blockers. Türkiye Klinikleri J Med Sci 27:328–334
   Web of Science ®Google Scholar
• Errol RN, Robinson JN. (2001). A systematic approach to the management of preterm labor. Semin Perinatol 25:223–235
   PubMed Web of Science ®Google Scholar
• Ferguson JE 2nd, Schutz T, Pershe R, et al. (1989). Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 161:1485–1490
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). (1980). Ritodrine approved for premature labor: FDA. Drug Bull 10:22–23
   Google Scholar
• Food and Drug Administration (FDA). FDA Pregnancy Categories. Available at: http://www.drugs.com/pregnancy-categories.html. Accessed on May 2014
   Google Scholar
• Fort DJ, Stover EL, Bantle JA, et al. (2001). Evaluation of a reproductive toxicity assay using Xenopus laevis: boric acid, cadmium and ethylene glycol monomethyl ether. J Appl Toxicol 21:41–52
   PubMed Web of Science ®Google Scholar
• Fort DJ, Stover EL, Farmer DR, Lemen JK. (2000). Assessing the predictive validity of frog embryo teratogenesis assay – Xenopus (FETAX). Teratogen Carcinog Mutagen 20:87–98
   PubMed Web of Science ®Google Scholar
• Freysz H, Willard D, Lehr A, et al. (1977). A long term evaluation of infants who received a beta-mimetic drug while in utero. J Perinat Med 5:94–99
   PubMed Web of Science ®Google Scholar
• Gallagher LA, Gautieri RF. (1992). Influence of a combination of ritodrine and nifedipine on the isolated rat uterus. Res Commun Chem Pathol Pharmacol 75:3–18
   PubMedGoogle Scholar
• Groome LJ, Goldenberg RL, Cliver SP. (1992). Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. Am J Obstet Gynecol 167:873–879
   PubMed Web of Science ®Google Scholar
• Gruber W, Baumgarten H, Baumung H. Fröhlich: Der Einfluß kurzzeitiger Infusion von Ritodrine auf Blutzucker, Insulin und Somatotropes Hormon. BAUMGARTEN, K., A. WESSELIUS DE CASPARIS: Proceedings of the Internat. Symposium on “the treatment of foetal risks”, Baden, 11. Mai 1972. University of Vienna; 1973
   Google Scholar
• Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. (1999). Tocolytics for preterm labor: a systematic review. Obstet Gynecol 94:869–877
   PubMed Web of Science ®Google Scholar
• Haas DM, Caldwell DM, Kirkpatrick P, et al. (2012). Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 345:e6226
   PubMed Web of Science ®Google Scholar
• Harake B, Gilbert RD, Ashwal S, Power GG. (1987). Nifedipine: effects on fetal and maternal hemodynamics in pregnant sheep. Am J Obstet Gynecol 157:1003–1008
   PubMed Web of Science ®Google Scholar
• Higby K, Suiter CR. (1999). A risk-benefit assessment of therapies for premature labour. Drug Saf 21:35–56
   PubMed Web of Science ®Google Scholar
• Higby K, Xenakis EMJ, Pauerstein CJ. (1993). Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 168:1247–1259
   PubMed Web of Science ®Google Scholar
• How HY, Hughes SA, Vogel RL, et al. (1995). Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 173:1518–1522
   PubMed Web of Science ®Google Scholar
• Kashanian M, Bahasadri S, Zolali, B. (2011). Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynaecol Obstet 113:192–195
   PubMed Web of Science ®Google Scholar
• Katz VL, Seeds JW. (1989). Fetal and neonatal cardiovascular complications from beta-sympathomimetic therapy for tocolysis. Am J Obstet Gynecol 161:1–4
   PubMed Web of Science ®Google Scholar
• King J, Flenady V, Cole S, Thornton S. (2005). Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev CD001992. DOI: 10.1002/14651858.CD001992.pub2
   Google Scholar
• King JF, Flenady VJ, Papatsonis DN, et al. (2003). Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev CD002255. DOI: 10.1002/14651858.CD002255
   Google Scholar
• Klymkowsky M. (2011). Two-headed Xenopus laevis tadpole. National Institute of General Medical Sciences (NIGMS). Available at: http://images.nigms.nih.gov/index.cfm?event=viewDetail&imageID: 2755. Accessed on July 22, 2013
   Google Scholar
• Koks CA, Brölmann HA, de Kleine MJ, Manger PA. (1998). A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur J Obstet Gynecol Reprod Biol 77:171–176
   PubMed Web of Science ®Google Scholar
• Larmon JE, Ross BS, May WL, et al. (1999). Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am J Obstet Gynecol 181:1432–1437
   PubMed Web of Science ®Google Scholar
• Laros RK Jr, Joseph A, Kitterman JA, et al. (1991). Outcome of very low birth weight infants exposed to β-sympathomimetics in utero. Am J of Obstet Gynecol 164:1657–1665
   PubMed Web of Science ®Google Scholar
• Leake RD, Hobel CJ, Okada DM, et al. (1983). Neonatal metabolic effects of oral ritodrine hydrochloride administration. Pediatr Pharmacol 3:101–106
   PubMedGoogle Scholar
• Li X, Zhang Y, Shi Z. (2005). Ritodrine in the treatment of preterm labour: a meta-analysis. Indian J Med Res 121:120–127
   PubMed Web of Science ®Google Scholar
• Lindi C, Montorfano G, Rossi F, et al. (2001). Effect of ethanol exposure on Xenopus embryo lipid composition. Alcohol Alcohol 36:388–392
   PubMed Web of Science ®Google Scholar
• Magee LA, Schick B, Donnenfeld AE, et al. (1996). The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174:823–828
   PubMed Web of Science ®Google Scholar
• Meyer WR, Randall HW, Graves WL. (1990). Nifedipine versus ritodrine for suppressing preterm labor. J Reprod Med 35:649–653
   PubMed Web of Science ®Google Scholar
• Nandita M, Vincent C, Verma RN, Desai VA. (2007). Maternal and fetal cardiovascular side effects of nifedipine and ritodrine used as tocolytics. J Obstet Gynecol India 57:131–134
   Google Scholar
• The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). (2000). Background Review Document. Frog Embryo Teratogenesis Assay – Xenopus (FETAX) March 10. Available at: http://ntp.niehs.nih.gov/iccvam/docs/fetax2000/brd/fetax-brd-all.pdf. Accessed on July 22, 2013
   Google Scholar
• The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). (2004). FETAX Background Review document. Executive Summary, ES1–ES16, Appendix 13, FETAX TEST Method Protocol
   Google Scholar
• New drug application, no.18280, for ritodrine hydrochloride submitted to the FDA on March 8, 1979, by Mid-West Medical Research, Inc, Columbus, Ohio, on behalf of Philips-Duphar, BV, Weesp, the Netherlands
   Google Scholar
• Nieuwkoop PD, Faber J. (1994). Normal Table of Xenopus laevis (Daudin). Newyork & London: Garland Publishing, INC
   Google Scholar
• Nochimson DJ, Riffel HD, Sze Ya, et al. (1974). The effects of ritrodrine hydrochloride on uterine activity and the caidiovascular system. Am J Obstet Gynec 118:523
   PubMed Web of Science ®Google Scholar
• O'Brien E, Prietz A, Dietrich DR. (2005). Investigation of the teratogenic potential of ochratoxin A and B using the FETAX system. Birth Defects Res B Dev Reprod Toxicol 74:417–423
   PubMed Web of Science ®Google Scholar
• Osano O, Oladimeji AA, Kraak MH, Admiraal W. (2002). Teratogenic effects of amitraz, 2,4-dimethylaniline, and paraquat on developing frog (Xenopus) embryos. Arch Environ Contam Toxicol 43:42–49
   PubMed Web of Science ®Google Scholar
• Ozcan T, Turan C, Ekici E, et al. (1995). Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage. Gynecol Obstet Invest 39:60–62
   PubMed Web of Science ®Google Scholar
• Papatsonis D, Flenady V, Cole S, Liley H. (2005). Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev (3):CD004452
   PubMedGoogle Scholar
• Prati M, Biganzoli E, Boracchi P, et al. (2000). Ecotoxicological soil evaluation by FETAX. Chemosphere 41:1621–1628
   PubMed Web of Science ®Google Scholar
• Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. (2001). Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 25:316–340
   PubMed Web of Science ®Google Scholar
• Renaud R, Irrmann M, Flynn M, et al. (1973). The treatment of premature iabour with Ritodrine hydrochloride. Baumgarten K, Wesselius De Casparis A. Proceedings of the Internat. Symposium on the “Treatment of foetal risks”, Baden, 11. Mai 1972, University of Vienna
   Google Scholar
• Rust OA, Bofill JA, Arriola RM, et al. (1996). The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 175:838–842
   PubMed Web of Science ®Google Scholar
• Sabourin TD, Faulk RT, Goss LB. (1985). The efficacy of three non-mammalian test systems in the identification of chemical teratogens. J Appl Toxicol 5:227–233
   PubMed Web of Science ®Google Scholar
• Salimetrics. Inter- and Intra-Assay Coefficients of Variability.pdf. http://www.salimetrics.com/assets/documents/Spit_Tips_-Inter__Intra_Assay_Coefficients_of_Variability.pdf?/documents. Accessed on May 12, 2014
   Google Scholar
• Shenker L. (1965). Effect of isoxsuprine on fetal heart rate and fetal electrocardiogram. Obstet Gynecol 26:104–109
   Web of Science ®Google Scholar
• Sorensen HT, Steffensen FH, Olesen C, et al. (1998). Pregnancy outcome in women exposed to calcium channel blockers. Reprod Toxicol 12:383–384
   PubMed Web of Science ®Google Scholar
• Ulmsten U. (1984). Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist. Arch Gynecol 236:69–72
   PubMedGoogle Scholar
• Ulmsten U, Andersson KE, Wingerup L. (1980). Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 229:1–5
   PubMedGoogle Scholar
• Van Assche FA, Aerts L. (1982). The effect of beta-sympathomimetics on the fetal endocrine pancreas. Eur J Obstet Gynecol Reprod Biol 15:395–400
   Google Scholar
• Webb RC. (2003). Smooth muscle contraction and relaxation. Adv Physiol Educ 27:201–206
   PubMed Web of Science ®Google Scholar
• Young RC, Smith LH, McLaren MD. (1993). T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells. Am J Obstet Gynecol 169:785–792
   PubMed Web of Science ®Google Scholar
• Zhu B, Fu Y. (1996). Treatment of preterm labor with ritodrine. Zhonghua Fu Chan Ke Za Zhi 31:721–723
   PubMedGoogle Scholar